122 related articles for article (PubMed ID: 33797370)
1. Predicting Metabolic Reaction Networks with Perturbation-Theory Machine Learning (PTML) Models.
Diéguez-Santana K; Casañola-Martin GM; Green JR; Rasulev B; González-Díaz H
Curr Top Med Chem; 2021; 21(9):819-827. PubMed ID: 33797370
[TBL] [Abstract][Full Text] [Related]
2. Perturbation-Theory and Machine Learning (PTML) Model for High-Throughput Screening of Parham Reactions: Experimental and Theoretical Studies.
Simón-Vidal L; García-Calvo O; Oteo U; Arrasate S; Lete E; Sotomayor N; González-Díaz H
J Chem Inf Model; 2018 Jul; 58(7):1384-1396. PubMed ID: 29898360
[TBL] [Abstract][Full Text] [Related]
3. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
[TBL] [Abstract][Full Text] [Related]
4. PTML Model of ChEMBL Compounds Assays for Vitamin Derivatives.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva Caracuel E; González-Díaz H
ACS Comb Sci; 2020 Mar; 22(3):129-141. PubMed ID: 32011854
[TBL] [Abstract][Full Text] [Related]
5. PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; Montemore MM; González-Díaz H
Mol Pharm; 2020 Jul; 17(7):2612-2627. PubMed ID: 32459098
[TBL] [Abstract][Full Text] [Related]
6. Modeling complex metabolic reactions, ecological systems, and financial and legal networks with MIANN models based on Markov-Wiener node descriptors.
Duardo-Sánchez A; Munteanu CR; Riera-Fernández P; López-Díaz A; Pazos A; González-Díaz H
J Chem Inf Model; 2014 Jan; 54(1):16-29. PubMed ID: 24320872
[TBL] [Abstract][Full Text] [Related]
7. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEMBL Data for Antiretroviral Compounds.
Vásquez-Domínguez E; Armijos-Jaramillo VD; Tejera E; González-Díaz H
Mol Pharm; 2019 Oct; 16(10):4200-4212. PubMed ID: 31426639
[TBL] [Abstract][Full Text] [Related]
8. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract][Full Text] [Related]
9. New Markov-Shannon Entropy models to assess connectivity quality in complex networks: from molecular to cellular pathway, Parasite-Host, Neural, Industry, and Legal-Social networks.
Riera-Fernández P; Munteanu CR; Escobar M; Prado-Prado F; Martín-Romalde R; Pereira D; Villalba K; Duardo-Sánchez A; González-Díaz H
J Theor Biol; 2012 Jan; 293():174-88. PubMed ID: 22037044
[TBL] [Abstract][Full Text] [Related]
10. Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2019 Nov; 11(45):21811-21823. PubMed ID: 31691701
[TBL] [Abstract][Full Text] [Related]
11. Modeling Antibacterial Activity with Machine Learning and Fusion of Chemical Structure Information with Microorganism Metabolic Networks.
Nocedo-Mena D; Cornelio C; Camacho-Corona MDR; Garza-González E; Waksman de Torres N; Arrasate S; Sotomayor N; Lete E; González-Díaz H
J Chem Inf Model; 2019 Mar; 59(3):1109-1120. PubMed ID: 30802402
[TBL] [Abstract][Full Text] [Related]
12. Predicting coated-nanoparticle drug release systems with perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2020 Jul; 12(25):13471-13483. PubMed ID: 32613998
[TBL] [Abstract][Full Text] [Related]
13. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioeconomic data of U.S. counties.
Herrera-Ibatá DM; Pazos A; Orbegozo-Medina RA; Romero-Durán FJ; González-Díaz H
Biosystems; 2015 Jun; 132-133():20-34. PubMed ID: 25916548
[TBL] [Abstract][Full Text] [Related]
14. IFPTML mapping of nanoparticle antibacterial activity
Ortega-Tenezaca B; González-Díaz H
Nanoscale; 2021 Jan; 13(2):1318-1330. PubMed ID: 33410431
[TBL] [Abstract][Full Text] [Related]
15. PTML Multi-Label Algorithms: Models, Software, and Applications.
Ortega-Tenezaca B; Quevedo-Tumailli V; Bediaga H; Collados J; Arrasate S; Madariaga G; Munteanu CR; Cordeiro MNDS; González-Díaz H
Curr Top Med Chem; 2020; 20(25):2326-2337. PubMed ID: 32938352
[TBL] [Abstract][Full Text] [Related]
16. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
[TBL] [Abstract][Full Text] [Related]
17. Error Tolerance of Machine Learning Algorithms across Contemporary Biological Targets.
Kaiser TM; Burger PB
Molecules; 2019 Jun; 24(11):. PubMed ID: 31167452
[TBL] [Abstract][Full Text] [Related]
18. Machine learning techniques for mortality prediction in critical traumatic patients: anatomic and physiologic variables from the RETRAUCI study.
Serviá L; Montserrat N; Badia M; Llompart-Pou JA; Barea-Mendoza JA; Chico-Fernández M; Sánchez-Casado M; Jiménez JM; Mayor DM; Trujillano J
BMC Med Res Methodol; 2020 Oct; 20(1):262. PubMed ID: 33081694
[TBL] [Abstract][Full Text] [Related]
19. Discriminant analysis and machine learning approach for evaluating and improving the performance of immunohistochemical algorithms for COO classification of DLBCL.
Perfecto-Avalos Y; Garcia-Gonzalez A; Hernandez-Reynoso A; Sánchez-Ante G; Ortiz-Hidalgo C; Scott SP; Fuentes-Aguilar RQ; Diaz-Dominguez R; León-Martínez G; Velasco-Vales V; Cárdenas-Escudero MA; Hernández-Hernández JA; Santos A; Borbolla-Escoboza JR; Villela L
J Transl Med; 2019 Jun; 17(1):198. PubMed ID: 31185999
[TBL] [Abstract][Full Text] [Related]
20. Radiogenomics of lower-grade gliomas: machine learning-based MRI texture analysis for predicting 1p/19q codeletion status.
Kocak B; Durmaz ES; Ates E; Sel I; Turgut Gunes S; Kaya OK; Zeynalova A; Kilickesmez O
Eur Radiol; 2020 Feb; 30(2):877-886. PubMed ID: 31691122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
